Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Hepatitis Monthly|January 11, 2017
Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective CohortPiero Luigi Almasio, Anna Licata, Marcello Maida, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 11, 2015
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis CSalvatore Petta, Marcello Maida, Stefania Grimaudo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 8, 2020
PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver DiseaseGrazia Pennisi, Rosaria Maria Pipitone, Calogero Cammà, et al.
Frontiers in Cell and Developmental Biology|July 12, 2021
PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19Stefania Grimaudo, Emanuele Amodio, Rosaria Maria Pipitone, et al.
Journal of Clinical Medicine|October 20, 2020
SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational StudyEmanuele Amodio, Rosaria Maria Pipitone, Stefania Grimaudo, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivativesRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Cancers|August 6, 2020
Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision AnalysisGiuseppe Cabibbo, Ciro Celsa, Marco Enea, et al.
International Immunopharmacology|January 23, 2003
Chemically modified tetracyclines induce cytotoxic effects against J774 tumour cell line by activating the apoptotic pathwayPietro D'Agostino, Viviana Ferlazzo, Salvatore Milano, et al.
European Journal of Medicinal Chemistry|December 3, 2015
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylationRomeo Romagnoli, Pier Giovanni Baraldi, Filippo Prencipe, et al.
Pageof 9